Drug Shortage Report for 5% DEXTROSE INJECTION
Report ID | 154485 |
Drug Identification Number | 02403536 |
Brand name | DEXTROSE 5% INJECTION |
Common or Proper name | Dextrose 5% Injection freeflex® Bag 50mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50ML |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-02-04 |
Estimated end date | 2022-03-22 |
Actual end date | 2022-03-30 |
Shortage status | Resolved |
Updated date | 2022-07-07 |
Company comments | Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption on our Dextrose 5% Injection freeflex® Bag 50mL effective today, February 4, 2022 until March 22, 2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-07-07 | French | Compare |
v3 | 2022-07-07 | English | Compare |
v2 | 2022-02-08 | French | Compare |
v1 | 2022-02-08 | English | Compare |
Showing 1 to 4 of 4